Skip to content

Epidural Versus Low-dose Spinal for Analgesia of Late First Stage of Labor

Epidural Versus Low-dose Spinal for Analgesia of Late First Stage of Labor: A Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05056142
Enrollment
100
Registered
2021-09-24
Start date
2021-09-14
Completion date
2022-10-01
Last updated
2022-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Related

Brief summary

The aim of this study is to compare the effect of epidural analgesia versus low-dose spinal analgesia in parturient in the late first stage of labor regarding time needed to perform the block, duration of the intra- and postoperative analgesia and incidence of procedure related adverse events.

Interventions

PROCEDUREEpidural Anesthesia

Patients will receive epidural analgesia with 15 ml isobaric bupivacaine 0.125% plus fentanyl 2 μg/mL.

Patients will receive Spinal analgesia with 5 mg bupivacaine and 25 μg of fentanyl in a 2 ml volume.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Parturient with normal vaginal delivery in late first stage of labor (cervical dilatation ≥ 6 cm by examination) * Aged 18-40 years old * Single, term pregnant with normal fetal heart rate * Request neuroaxial analgesia

Exclusion criteria

* Parturient who refuses to participate, * American Society of Anesthesiologists (ASA) physical status \>II, * Body mass index more than 35 kg/m2 * Severe pre-eclampsia or eclampsia * Uncontrolled thyrotoxicosis * Cardiovascular troubles (e.g. stenotic valvular heart disease or cardiomyopathy) * Increased intracranial tension due to a space-occupying lesion * Any contraindication to regional anesthesia such as local skin or soft tissue infection, coagulopathy or receiving anticoagulant therapy, thrombocytopenic, uncorrected hypovolemia, preexisting neurologic deficits, spinal deformity or previous spine surgery. * Hypersensitivity to the study drugs * Parturient who scheduled for emergency cesarean section due to fetal distress, antepartum hemorrhage, multiple gestation or fetal malpresentation

Design outcomes

Primary

MeasureTime frameDescription
The time to perform the blockIntraoperativeThe time from the preparation of the block until the full injection of anesthetic drugs,

Secondary

MeasureTime frameDescription
Mean arterial blood pressure (MAP)IntraoperativeMAP will be recorded at baseline; 5 minutes prior to the neuroaxial block, and at 5 minutes, 10 minutes, 15 minutes, and 20 minutes after the injection of the local anesthetic and then every 15 minutes till the end of third stage of labor
Heart rate (HR)IntraoperativeHR will be recorded at baseline; 5 minutes prior to the neuroaxial block, and at 5 minutes, 10 minutes, 15 minutes, and 20 minutes after the injection of the local anesthetic and then every 15 minutes till the end of third stage of labor
Number of participnts with Postoperative nausea and vomiting (PONV)First 24 hours postoperativelyPONV will be recorded and categorized as 'no PONV, mild PONV, moderate PONV, and severe PONV'

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026